Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cutland

Showing results (161-170 of 173) with videos related to

Pageof 18
Sort By:
Vaccine|July 27, 2025
Longitudinal Meta-cohort study protocol using systems biology to identify vaccine safety biomarkersJoann Diray-Arce, Ana C Chang, Sara Moradipoor, et al.
The Lancet. Infectious Diseases|August 11, 2022
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscapeNatalie I Mazur, Jonne Terstappen, Ranju Baral, et al.
Nature Medicine|May 13, 2024
High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine responseAlexander J Mentzer, Alexander T Dilthey, Martin Pollard, et al.
Journal of Global Health|November 5, 2021
External validation of the RISC, RISC-Malawi, and PERCH clinical prediction rules to identify risk of death in children hospitalized with pneumoniaChris A Rees, Shubhada Hooli, Carina King, et al.
Nature Medicine|February 23, 2021
Malaria is a cause of iron deficiency in African childrenJohn Muthii Muriuki, Alexander J Mentzer, Ruth Mitchell, et al.
The New England Journal of Medicine|March 16, 2021
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 VariantShabir A Madhi, Vicky Baillie, Clare L Cutland, et al.
BMJ Global Health|July 7, 2025
Development and validation of a novel clinical risk score to predict hypoxaemia in children with pneumonia using the WHO PREPARE datasetRainer Tan, Arjun Chandna, Tim Colbourn, et al.
BMJ Global Health|April 16, 2022
Derivation and validation of a novel risk assessment tool to identify children aged 2-59 months at risk of hospitalised pneumonia-related mortality in 20 countriesChris A Rees, Tim Colbourn, Shubhada Hooli, et al.
The New England Journal of Medicine|July 30, 2020
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in InfantsShabir A Madhi, Fernando P Polack, Pedro A Piedra, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 22, 2023
In-hospital mortality risk stratification in children aged under 5 years with pneumonia with or without pulse oximetry: A secondary analysis of the Pneumonia REsearch Partnership to Assess WHO REcommendations (PREPARE) datasetShubhada Hooli, Carina King, Eric D McCollum, et al.
Pageof 18

Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
Vaccine|July 27, 2025
Longitudinal Meta-cohort study protocol using systems biology to identify vaccine safety biomarkersJoann Diray-Arce, Ana C Chang, Sara Moradipoor, et al.
The Lancet. Infectious Diseases|August 11, 2022
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscapeNatalie I Mazur, Jonne Terstappen, Ranju Baral, et al.
Nature Medicine|May 13, 2024
High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine responseAlexander J Mentzer, Alexander T Dilthey, Martin Pollard, et al.
Journal of Global Health|November 5, 2021
External validation of the RISC, RISC-Malawi, and PERCH clinical prediction rules to identify risk of death in children hospitalized with pneumoniaChris A Rees, Shubhada Hooli, Carina King, et al.
Nature Medicine|February 23, 2021
Malaria is a cause of iron deficiency in African childrenJohn Muthii Muriuki, Alexander J Mentzer, Ruth Mitchell, et al.
The New England Journal of Medicine|March 16, 2021
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 VariantShabir A Madhi, Vicky Baillie, Clare L Cutland, et al.
BMJ Global Health|July 7, 2025
Development and validation of a novel clinical risk score to predict hypoxaemia in children with pneumonia using the WHO PREPARE datasetRainer Tan, Arjun Chandna, Tim Colbourn, et al.
BMJ Global Health|April 16, 2022
Derivation and validation of a novel risk assessment tool to identify children aged 2-59 months at risk of hospitalised pneumonia-related mortality in 20 countriesChris A Rees, Tim Colbourn, Shubhada Hooli, et al.
The New England Journal of Medicine|July 30, 2020
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in InfantsShabir A Madhi, Fernando P Polack, Pedro A Piedra, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 22, 2023
In-hospital mortality risk stratification in children aged under 5 years with pneumonia with or without pulse oximetry: A secondary analysis of the Pneumonia REsearch Partnership to Assess WHO REcommendations (PREPARE) datasetShubhada Hooli, Carina King, Eric D McCollum, et al.
Pageof 18